Articles related to Neurology

Even if menopause does lead to some gray matter loss, it won’t automatically lead to future cognitive decline or dementia.

“The key word is association. This study does not establish causality. For absolute, catastrophic harm to an appropriately selected, monitored pain patient, the risk is small.” – Sean Mackey, MD, PhD, Chief of the Division of Stanford Pain Medicine

Studies have shown a mean effect size with CBTI of 0.96 compared with 0.87 for pharmacotherapy, suggesting similar efficacy in short term but CBTI seems to have longer-lasting effects.

Twelve months after transplantation with the lower dose, mean scores decreased by 30.6 points during off time (a 52.82% improvement from baseline) and by 12.9 points during on time (a 54.67% improvement).

“The more frequently the brain is exposed to migraine attacks, the more likely it is to become sensitized…early intervention is critical.” – Dr. Andrew Blumenfeld, Director of the San Diego Headache Center and The Los Angeles Headache Center San Diego/Los Angeles.

According to Karthikeyan Tangavelou, PhD, a professor in the Department of Molecular Genetics & Microbiology at the UNM School of Medicine: “If you stop tau synthesis by targeting OTULIN in neurons, you can restore a healthy brain and prevent brain aging.”